<bill session="118" type="h" number="1512" updated="2024-07-24T15:23:15Z">
  <state datetime="2023-03-09">REFERRED</state>
  <status>
    <introduced datetime="2023-03-09"/>
  </status>
  <introduced datetime="2023-03-09"/>
  <titles>
    <title type="display">Greater Access to Contraceptive Options Act</title>
    <title type="short" as="introduced">Greater Access to Contraceptive Options Act</title>
    <title type="official" as="introduced">To allow women greater access to a wider range of self-administered contraceptives approved under the Federal Food, Drug, and Cosmetic Act.</title>
  </titles>
  <sponsor bioguide_id="M000194"/>
  <cosponsors/>
  <actions>
    <action datetime="2023-03-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-03-09" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2023-03-17">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2023-10-02T19:14:10Z" status="Introduced in House">Greater Access to Contraceptive Options Act

This bill requires the Food and Drug Administration to prioritize review of supplemental applications for over-the counter, self-administered contraceptives (i.e., contraception that is administered without the intervention of a health care professional).</summary>
</bill>
